The CBSE Class 12 Biology exam is scheduled for March 27, 2026. Experts advise students to focus on key topics like Genetics, ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Many are now aware of the power that Texas Tech wields on the recruiting front. It’s been most obvious during the Transfer Portal window, but the Big 12 program is making quite the splash on the high ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

SAN JOSE — Zebra Technologies and bioMerieux reported to the state Employment Development Department their separate decisions to cut jobs in moves that will eliminate a combined 196 positions in San ...

Gov. Maura Healey is expected to be in Norton Wednesday morning to announce some good news: a $250 million expansion of a manufacturing plant run by Alnylam Pharmaceuticals, a publicly traded biotech ...

Chai Discovery, a biotech startup with backing from OpenAI, announced a $130 million Series B round at a $1.3 billion valuation on Monday. The round was led by General Catalyst and Oak HC/FT, the ...

The iShares Biotechnology ETF is up over 32% in six months on rate cut expectations and potential sector rotation. The State Street SPDR S&P Biotech ETF has surged 45% in six months but remains 27% ...

The 2025 Big 12 season has come to an end, and the final results look far different than preseason outlooks. Texas Tech blew away expectations to earn its first outright conference title since 1955, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min This Cambridge biotech is ...

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the best biotech stocks to buy according to Wall Street analysts. On December 4, Citi analyst Yigal Nochomovitz reiterated a Buy rating on ...

Dec 10 (Reuters) - French biotech company Abivax's (ABVX.PA), opens new tab shares rose by over 20% on Wednesday on market rumours that U.S. pharma giant Eli Lilly (LLY.N), opens new tab could make an ...